# Celldex Therapeutics, Inc.: Form 8-K, filed Jan 28, 2022

- Company: [Celldex Therapeutics, Inc.](/companies/cldx.md) (CIK 744218)
- Form: 8-K
- Filed: 2022-01-28
- Accepted by EDGAR: Jan 28, 2022, 16:01 ET
- Period: 2022-01-25
- Accession: 0001104659-22-008977
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/744218/000110465922008977/tm224432d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/744218/000110465922008977/

## Items reported

- Item 5.03: Amendment to articles or bylaws
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/744218/000110465922008977/tm224432d1_8k.htm

Filed Jan 28, 2022.
Source: SEC EDGAR, the filing index for accession 0001104659-22-008977. Last ingested by Listed: Nov 5, 2026, 19:04 ET. No prices; not investment advice.
